Please login to the form below

Not currently logged in
Email:
Password:

generic drugs

This page shows the latest generic drugs news and features for those working in and with pharma, biotech and healthcare.

US insurers can peg access to ICER value reviews

US insurers can peg access to ICER value reviews

The adoption of ICER guidance is part of an array of approaches taken to limit drug costs by the PBM, along with encouraging the use of generic substitution for brandname drugs, ... Sanofi/Regeneron, GlaxoSmithKline’s severe asthma therapy Nucala

Latest news

More from news
Approximately 3 fully matching, plus 296 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The main drivers of revenue for Roche are well-established, standard-of-care blockbuster oncology drugs including Rituxan, Herceptin and Avastin. ... Roche will likely take the biggest loss in Europe, where nationalised healthcare systems are keen to

  • Deal Watch June 2016 Deal Watch June 2016

    The three deals with Mayne Pharma, Impax Laboratories and Dr Reddy's, for a combined value of over $1.5bn, cover portfolios of marketed and approved generic drugs, drugs currently pending ... 8 generic drugs - filed ANDAs pending approval and an approved

  • Cost containment and the German market Cost containment and the German market

    They represent an established instrument of cost control, especially in the generic segment, as 93% of all drugs under rebate contract are generics. ... Focusing on patented drugs, the price difference to the generic segment is significant.

  • Deal Watch February 2016 Deal Watch February 2016

    Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of branded, OTC and generic drugs.

  • Social media and inflation penalties for generic drugs Social media and inflation penalties for generic drugs

    Today. Per the legislation, generic drugs will have to pay an additional rebate on top of the basic rebate. ... As a result, 340B prices for generic drugs may be lowered as Medicaid URAs become higher.

More from intelligence
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest appointments

  • Elite Pharma names Actavis VP as CEO Elite Pharma names Actavis VP as CEO

    These include 12 generic drugs already approved by the US Food and Drug Administration (FDA) but are yet to be marketed. ... An additional generic product is under review. “ Nasrat has broad experience in both branded and generic pharmaceuticals as

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics